Sutro Biopharma (STRO) Stock: Buy, Sell, or Hold?
STRO - Sutro Biopharma, Inc.
$10.79
-0.75 (-6.50%)
▼
5d:
+2.57%
30d:
-33.11%
90d:
-54.28%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When STRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: STRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: STRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: STRO is currently trading at $10.79, which is considered oversold relative to its 30-day fair value range of $12.36 to $16.50.
Technical Outlook: Technically, STRO is in a strong downtrend. Immediate support is located at $10.36, while resistance sits at $16.20. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: STRO scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $47.23 (+337.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STRO is in a strong downtrend. Immediate support is located at $10.36, while resistance sits at $16.20. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: STRO scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $47.23 (+337.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.36 -
$16.50
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 337.7% below Wall St target ($47.23)
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$12.36 -
$16.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.36
Resistance Level
$16.21
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.74
Wall Street Target
$47.23
(+337.7%)
Revenue Growth (YoY)
-84.6%
Share & Embed Analysis
Last updated: October 22, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
